| Name | Title | Contact Details |
|---|
HealthTrans is one of the leading companies in the Healthcare, Pharmaceuticals, and Biotech sector.
lcelyx was founded in 2010 with venture capital backing based on Gut Sensory Modulation (GSM) technology. Elcelyx`s proprietary, first-in-class Gut Sensory Modulators are delivered directly to the lower gut where they act on molecular targets to elicit physiological and pharmacological effects. The Elcelyx proprietary product candidate, NewMet for Type 2 diabetes is entering Phase 2b development and is a blockbuster opportunity designed to address the unmet needs in the oral anti-diabetic market. Elcelyx is led by an experienced management team and Board of Directors with track records of success in drug development and commercialization. Premier investors along with seasoned scientists and clinicians support the team. In September 2013, Elcelyx announced the formation of NaZura BioHealth Inc, a separate company established to focus on the development on non-NewMet assets.
St. Luke`s, a regional health care system, offers a comprehensive continuum of care serving the 17-county region of northeastern Minnesota, northwestern Wisconsin and the Upper Peninsula of Michigan. The system includes St. Luke`s Hospital in Duluth, Minnesota, Lake View Hospital in Two Harbors, Minnesota, and 11 primary and 27 specialty clinics. Primary care clinics are located in Duluth, Hermantown, Hibbing, Two Harbors, Mountain Iron and Silver Bay, Minnesota, and Ashland and Superior, Wisconsin. Urgent care and Q Care express medical services are also available. St. Luke`s is designated by the American College of Surgeons and the state of Minnesota Department of Health as a Level II trauma center. St. Luke`s Regional Cancer Center offers treatments including Stereotactic Radiosurgery (SRS) and radiation oncology. St. Luke`s Regional Heart Center includes cardiology, cardiothoracic surgery, cardiac rehab services and catheterization lab. Other specialties include obstetrics, gynecology, plastic surgery, pulmonary medicine, allergy, neurosurgery, dermatology, endocrinology, gastroenterology, infectious disease, surgery, occupational health, orthopedics and sports medicine, pediatrics, physical medicine and rehab, rheumatology, psychiatry, urology, hospice and home care. With the University of Minnesota Duluth Medical School, St. Luke`s conducts clinical research in the areas of cancer, lung and heart disease through the Whiteside Institute for Clinical Research.
Based in the heart of Silicon Valley, Lumiata is an Artificial Intelligence company purpose-built for the healthcare industry. Powered by over 100 million patient data records, clinical, risk, and financial algorithms, Lumiata employs some of the nation`s leading data science and machine learning talent. Lumiata enriches payers` and providers` analytic and predictive capabilities with a platform and pre-built models that help to manage healthcare costs and risk.
Since 1983, Schulman has provided the research community with IRB review services of the highest quality. In establishing the IRB, our founders sought to promote clinical research by helping to safeguard the rights and welfare of clinical research subjects. Schulman’s team of dedicated professionals seeks to provide timely, quality services based on the foundation of respect for persons, beneficence and justice. Through continuous quality improvement and rigorous training on human subject protection, Schulman provides thorough, ethical, responsive and thoughtful review of research studies. By combining impeccable review standards, savvy industry insight, responsive customer service and innovative technological solutions, Schulman creates a review experience that goes beyond the expected. We look forward to continued collaboration with our colleagues in North America and around the world as we uphold our mission to protect the rights and welfare of clinical research subjects.